Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, includ…
Biotechnology
US, Plano [HQ]
Cash Flow Statements
10 Sheets · Starting from 2022In Million USD. Margins, Growth Rates In %
| Metric | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||
| Operating Cash Flow (OCF) | -68.00 | -88.00 | -44.00 | -19.00 | -83.00 | -83.00 | -251.00 | -322.00 | -235.00 | -204.00 | |
| Operating Cash (Net) | -68.00 | -88.00 | -44.00 | -19.00 | -83.00 | -83.00 | -251.00 | -322.00 | -235.00 | -204.00 | |
| Accounts Receivable | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Accounts Payable | - - | -1.00 | 2.00 | - - | -1.00 | 1.00 | -2.00 | 2.00 | 8.00 | 5.00 | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Change | -1.00 | -111.00 | -64.00 | -16.00 | -42.00 | -16.00 | 10.00 | -172.00 | -49.00 | 9.00 | |
| Other WC | -1.00 | -109.00 | -67.00 | -16.00 | -40.00 | -18.00 | 12.00 | -175.00 | -58.00 | 4.00 | |
| Investing Activities | |||||||||||
| Used Cash (Net) | 2.00 | - - | - - | - - | - - | - - | -2.00 | - - | -1.00 | -345.00 | |
| Capital Expenditure | - - | - - | - - | - - | - - | - - | -2.00 | - - | -1.00 | -3.00 | |
| Purchases of Investments | - - | - - | - - | - - | - - | - - | - - | - - | - - | -661.00 | |
| Sale/Maturity of Investment | - - | - - | - - | - - | - - | - - | - - | - - | - - | 320.00 | |
| Property, Plant, Equipment (P&PE) | - - | - - | - - | - - | - - | - - | -2.00 | - - | -1.00 | -3.00 | |
| Acquisitions (Net) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Investing Activities | 2.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Financing Activities | |||||||||||
| Used Cash (Net) | -1.00 | - - | - - | -62.00 | -128.00 | -292.00 | -580.00 | -477.00 | -9.00 | -1.00 | |
| Debt Repayment | - - | - - | - - | - - | - - | - - | - - | -167.00 | - - | - - | |
| Dividends Paid | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Common Stock
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Issued | - - | - - | - - | 64.00 | 108.00 | 233.00 | 492.00 | 333.00 | 333.00 | - - | |
| Repurchased | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Financing Activities | 2.00 | - - | - - | -2.00 | 19.00 | 58.00 | 87.00 | 310.00 | -324.00 | 1.00 | |
| Cash Balances | |||||||||||
| Begin of Period | 241.00 | 176.00 | 87.00 | 42.00 | 84.00 | 129.00 | 337.00 | 664.00 | 818.00 | 590.00 | |
| End of Period | 176.00 | 87.00 | 42.00 | 84.00 | 129.00 | 337.00 | 664.00 | 818.00 | 590.00 | 42.00 | |
| Change | -65.00 | -88.00 | -45.00 | 42.00 | 45.00 | 208.00 | 326.00 | 153.00 | -227.00 | -547.00 | |
| Non-Cash Balances | |||||||||||
| Depreciation and Amortization | 2.00 | 2.00 | 1.00 | - - | - - | - - | - - | 1.00 | 1.00 | 1.00 | |
| Stock Based Compensation | 2.00 | 1.00 | 2.00 | 2.00 | 6.00 | 10.00 | 26.00 | 57.00 | 56.00 | 58.00 | |
| Other | -37.00 | 18.00 | 17.00 | - - | - - | - - | 1.00 | 28.00 | 53.00 | 38.00 | |
| Highlighted metrics | |||||||||||
| Free Cash Flow (FCF) | -69.00 | -88.00 | -44.00 | -19.00 | -83.00 | -84.00 | -253.00 | -323.00 | -237.00 | -207.00 | |
| Cash Conversion Cycle (CCC) | - - | - - | - - | - - | - - | - - | -5.00 | - - | - - | - - | |
| Invested Capital | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
|||||||||||
| Forex Effect on Cash | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - |